The introduction of nicotinamide like a nicotine substitute in e-cigarette and smokeless items represents a substantial regulatory obstacle for the FDA. Nicotinamide does not have nicotinic receptor agonist activity and is known to work as a sedative at high dosages6. The claims made by Nicotine River, ECBlend, along with other distributors that th… Read More